Page last updated: 2024-08-26

fulvestrant and andrographolide

fulvestrant has been researched along with andrographolide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Parichatikanond, W; Pinthong, D; Reabroi, S; Tohkayomatee, R; Tungmunnithum, D	1

Other Studies

1 other study(ies) available for fulvestrant and andrographolide

Article	Year
Andrographolide Exhibits Anticancer Activity against Breast Cancer Cells (MCF-7 and MDA-MB-231 Cells) through Suppressing Cell Proliferation and Inducing Cell Apoptosis via Inactivation of ER-α Receptor and PI3K/AKT/mTOR Signaling. Molecules (Basel, Switzerland), 2022, May-31, Volume: 27, Issue:11 Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Diterpenes; Estrogen Receptor alpha; Female; Fulvestrant; Humans; MCF-7 Cells; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RNA, Messenger; TOR Serine-Threonine Kinases	2022

Article

Year

Andrographolide Exhibits Anticancer Activity against Breast Cancer Cells (MCF-7 and MDA-MB-231 Cells) through Suppressing Cell Proliferation and Inducing Cell Apoptosis via Inactivation of ER-α Receptor and PI3K/AKT/mTOR Signaling.

Molecules (Basel, Switzerland), 2022, May-31, Volume: 27, Issue:11

Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Diterpenes; Estrogen Receptor alpha; Female; Fulvestrant; Humans; MCF-7 Cells; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RNA, Messenger; TOR Serine-Threonine Kinases

2022